B1.7 Precision Phytotherapy Blueprint: A Multi-Molecular Botanical Alternative for Opioid-Sparing Pain Management

This paper outlines a hypothesized Precision Phytotherapy Blueprint (B1.7) designed to target chronic inflammatory pain mechanisms as an alternative to conventional Percocet (Oxycodone/Acetaminophen). By integrating Mitragynine (MOR partial agonist), Beta-Caryophyllene (CB2 agonist), and Curcumin (COX-2 inhibitor) into a high-bioavailability nanodelivery matrix, we propose a synergistic analgesic effect with a reduced side-effect profile. This document serves as a pre-experimental protocol with placeholders for future clinical validation.